share_log

寿仙谷:浙江寿仙谷医药股份有限公司和国信证券股份有限公司关于《关于请做好浙江寿仙谷医药股份有限公司公开发行可转债发审委会议准备工作的函》的回复

Shouxiangu: Response from Zhejiang Shouxiangu Pharmaceutical Co., Ltd. and Guoxin Securities Co., Ltd. to the “Letter on Please Complete Preparation for the Development and Review Committee Meeting on the Public Issuance of Convertible Bonds by Zhejiang Sh

SZSI ·  Aug 24, 2022 12:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more